USC inks licensing agreement for prostate cancer screening tool
20/20 Biolabs Inc. will commercialize a patented technology developed by James Hébert, Health Sciences Distinguished Professor in the Department of Epidemiology and Biostatistics, to assess health risks from rising levels of prostate-specific antigen.